---
{"dg-publish":true,"permalink":"/USMLE/Biochemistry/Maple syrup urine disease/"}
---

Definition: inherited genetic disorder characterized by the <span style="background:rgba(240, 200, 0, 0.2)">impaired break down of branched-chain amino acids (BCAA)</span>
# Epidemiology


---
# Etiology
autosomal recessive

---
# Pathophysiology
- Absent or deficient branched-chain alpha-ketoacid dehydrogenase → impaired degradation of BCAA (valine, leucine, isoleucine) → elevated α-ketoacid formation![Pasted image 20231117163430.png](/img/user/appendix/Pasted%20image%2020231117163430.png)

---
# Clinical features
- Symptom onset: <span style="background:rgba(240, 200, 0, 0.2)">early neonatal period</span>
- <span style="background:rgba(240, 200, 0, 0.2)">Vomiting, lethargy, poor feeding</span>
- <span style="background:rgba(240, 200, 0, 0.2)">Sweet-smelling urine (maple syrup or burnt sugar odor)</span>
- <span style="background:rgba(240, 200, 0, 0.2)">Intellectual disability</span>
- [[USMLE/Neurology/Dystonia\|Dystonia]]
- Damage to the CNS can be severe (elevated leucine level leads to brain injury)
- Death may occur without appropriate treatment

---
# Diagnostics
- Serum
	- Increased levels of alpha-ketoacids (especially leucine alpha-ketoacids)

---
# Treatment
- Avoid foods containing BCAA
- <span style="background:rgba(240, 200, 0, 0.2)">Supplementation of [[USMLE/Biochemistry/Vitamin B1\|thiamine]], a cofactor of branched-chain alpha-ketoacid dehydrogenase</span>

---
